Free Trial
NASDAQ:NYXH

Nyxoah (NYXH) Stock Price, News & Analysis

Nyxoah logo
$10.51 +0.46 (+4.58%)
Closing price 03/14/2025 03:59 PM Eastern
Extended Trading
$10.78 +0.27 (+2.52%)
As of 03/14/2025 05:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Nyxoah Stock (NASDAQ:NYXH)

Key Stats

Today's Range
$10.50
$11.57
50-Day Range
$9.25
$10.99
52-Week Range
$6.76
$20.00
Volume
184,921 shs
Average Volume
42,835 shs
Market Capitalization
$357.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.25
Consensus Rating
Buy

Company Overview

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Remove Ads

Nyxoah Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
39th Percentile Overall Score

NYXH MarketRank™: 

Nyxoah scored higher than 39% of companies evaluated by MarketBeat, and ranked 734th out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nyxoah has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Nyxoah has only been the subject of 1 research reports in the past 90 days.

  • Read more about Nyxoah's stock forecast and price target.
  • Earnings Growth

    Earnings for Nyxoah are expected to grow in the coming year, from ($1.91) to ($1.73) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nyxoah is -5.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nyxoah is -5.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Nyxoah's valuation and earnings.
  • Percentage of Shares Shorted

    0.65% of the float of Nyxoah has been sold short.
  • Short Interest Ratio / Days to Cover

    Nyxoah has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nyxoah has recently increased by 27.16%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nyxoah does not currently pay a dividend.

  • Dividend Growth

    Nyxoah does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.65% of the float of Nyxoah has been sold short.
  • Short Interest Ratio / Days to Cover

    Nyxoah has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nyxoah has recently increased by 27.16%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Nyxoah has a news sentiment score of -0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.77 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 15 news articles for Nyxoah this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Nyxoah insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.11% of the stock of Nyxoah is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Nyxoah's insider trading history.
Receive NYXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nyxoah and its competitors with MarketBeat's FREE daily newsletter.

NYXH Stock News Headlines

Nyxoah price target lowered to $15 from $16 at Stifel
Your Wealth is Under Attack
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
Nyxoah reports Q4 revenue EUR 1.3M
Nyxoah SA (NYXH) Q4 2024 Earnings Call Transcript
See More Headlines

NYXH Stock Analysis - Frequently Asked Questions

Nyxoah's stock was trading at $8.00 at the beginning of 2025. Since then, NYXH stock has increased by 31.4% and is now trading at $10.51.
View the best growth stocks for 2025 here
.

Nyxoah S.A. (NASDAQ:NYXH) issued its earnings results on Thursday, March, 13th. The company reported ($0.49) earnings per share for the quarter, missing analysts' consensus estimates of ($0.46) by $0.03. The firm earned $1.35 million during the quarter, compared to the consensus estimate of $2.02 million. Nyxoah had a negative net margin of 1,043.93% and a negative trailing twelve-month return on equity of 51.68%.

Nyxoah (NYXH) raised $83 million in an initial public offering (IPO) on Friday, July 2nd 2021. The company issued 2,760,000 shares at $30.00 per share.

Nyxoah's top institutional shareholders include Vestal Point Capital LP (8.59%), Millennium Management LLC (0.50%), AXA S.A. (0.26%) and Renaissance Technologies LLC (0.07%).

Shares of NYXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nyxoah investors own include PayPal (PYPL), Confluent (CFLT), Datadog (DDOG), Baidu (BIDU), Arcadia Biosciences (RKDA), SEA (SE) and ZoomInfo Technologies (ZI).

Company Calendar

Last Earnings
3/13/2025
Today
3/16/2025
Next Earnings (Estimated)
5/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NYXH
Employees
110
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$15.25
High Stock Price Target
$17.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+45.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-46,770,000.00
Net Margins
-1,043.93%
Pretax Margin
-1,036.49%

Debt

Sales & Book Value

Annual Sales
$4.52 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
28,232,000
Market Cap
$357.97 million
Optionable
Not Optionable
Beta
1.42
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:NYXH) was last updated on 3/16/2025 by MarketBeat.com Staff
From Our Partners